elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Papers
Communities
Institutions
beta
Research Intelligence
Lab
API & MCP
Pricing
Log in
Sign up
Home
/
Subjects
/
Lymphedema
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Lymphedema
RIS
0.001
(Research Intensity Score)
Papers
108
Top papers
Interventions for Breast Cancer–Related Lymphedema: Clinical Practice Guideline From the Academy of Oncologic Physical Therapy of APTA
2020 · 152 citations
Unraveling the Dynamics of Human Filarial Infections: Immunological Responses, Host Manifestations, and Pathogen Biology
2025 · 19 citations
Imaging and management of lymphedema in the era of precision oncology
2025 · 11 citations
Present and Future of Autologous Breast Reconstruction: Advancing Techniques to Minimize Morbidity and Complications, Enhancing Quality of Life and Patient Satisfaction
2025 · 8 citations
Long-Term Burden of Breast Cancer-Related Lymphedema
2024 · 11 citations
Newest papers
The Past, Present, and Future of Sentinel Lymph Node Biopsy in Breast Cancer
2026 · 2 citations
Traditional Chinese Medicine for Breast Cancer-Related Lymphedema: An Umbrella Review of Systematic Reviews and Meta-Analyses
2026
EXERT-BCHC: a prospective study of exercise regimens after breast cancer to improve skeletal muscle hypertrophy and conditioning
2026
Lymphedema: current treatment strategies and future directions in tissue engineering
2026
High Prevalence of Selenium Deficiency in Patients with Filarial Lymphedema
2026
A sample from the 100 top papers behind Lymphedema.
Create a free account to browse them all →
Lymphedema's history
Research intensity over time
Explore Lymphedema's full history
Hover any year for its value and switch resolutions with a free account. Personal adds monthly detail and the historical-intensity (HRI) line.
Create a free account
Already have an account?
Log in
to explore the data.
Close ✕
Lymphedema's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link